XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 3.47%63.82M | -3.73%28.39M | 149.70%17.61M | -24.62%8.46M | -32.74%9.36M | -43.15%61.67M | -10.95%29.49M | -85.06%7.05M | 231.77%11.22M | -43.85%13.92M |
Net income from continuing operations | 342.74%73.71M | -30.84%14.97M | -10.67%21.95M | 117.52%14.94M | 150.02%21.85M | -118.19%-30.37M | -83.22%21.64M | 63.38%24.57M | -983.69%-85.32M | -34.43%8.74M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | --97.09M | --0 | --0 | ---- | ---- |
Depreciation and amortization | 0.71%25.14M | -5.78%5.98M | -0.47%6.15M | 7.21%6.6M | 2.06%6.41M | -2.65%24.97M | -2.99%6.35M | -2.66%6.18M | -5.38%6.16M | 0.58%6.28M |
Deferred tax | -294.80%-8.73M | -5,700.00%-10.61M | 169.57%1.95M | 32.03%775K | -540.84%-842K | 98.13%-2.21M | 99.84%-183K | -11,124.00%-2.81M | 29,450.00%587K | 1,293.75%191K |
Other non cash items | -1,198.68%-19.99M | -9,286.63%-16.15M | -392.62%-4.32M | 181.60%811K | -245.58%-329K | 89.09%1.82M | -170.78%-172K | 510.33%1.48M | 20.50%288K | -5.04%226K |
Change In working capital | -20.93%-70.74M | 17.06%-3.44M | 41.00%-17.58M | -49.35%-23.91M | -202.11%-25.81M | -686.14%-58.5M | -144.27%-4.15M | -253.68%-29.79M | 17.04%-16.01M | -1,758.83%-8.54M |
-Change in receivables | -149.39%-6.56M | 18.44%29.2M | -2,429.00%-31.31M | 167.92%9.04M | -526.99%-13.48M | 203.47%13.27M | -23.25%24.65M | 95.67%-1.24M | 30.60%-13.3M | 11.91%3.16M |
-Change in inventory | 76.37%-8.31M | -133.04%-4.61M | 165.20%2.99M | 90.19%-1.84M | 81.22%-4.84M | 5.71%-35.16M | 172.82%13.96M | 62.61%-4.58M | -888.62%-18.78M | -212.13%-25.76M |
-Change in prepaid assets | 70.42%-4.75M | 8.03%-4.33M | 112.93%740K | -82.94%-1.56M | 108.26%395K | -309.48%-16.06M | -554.03%-4.71M | -3,743.95%-5.72M | -105.16%-850K | 41.95%-4.78M |
-Change in payables and accrued expense | 96.16%-338K | 29.85%-12.66M | 366.98%9.38M | -136.66%-14.68M | 31.20%17.62M | 32.83%-8.81M | -156.25%-18.05M | -82.60%2.01M | 80.85%-6.2M | -9.08%13.43M |
-Change in other working capital | -332.74%-50.79M | 44.83%-11.04M | 103.10%628K | -164.33%-14.87M | -571.04%-25.51M | -117.91%-11.74M | -577.63%-20.01M | -141.75%-20.26M | 72.50%23.12M | 1,025.64%5.42M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 3.47%63.82M | -3.73%28.39M | 149.70%17.61M | -24.62%8.46M | -32.74%9.36M | -43.15%61.67M | -10.95%29.49M | -85.06%7.05M | 231.77%11.22M | -43.85%13.92M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -21.03%-64.55M | -74.83%-45.72M | -0.22%-29.61M | -417.90%-9.94M | 2,819.82%20.73M | 22.58%-53.33M | 45.20%-26.15M | -715.54%-29.55M | 121.13%3.13M | 93.17%-762K |
Capital expenditure reported | 35.15%-18.11M | 51.59%-5.18M | 37.59%-3.99M | 24.09%-2.95M | 13.76%-5.99M | -13.52%-27.93M | -277.66%-10.7M | -0.69%-6.4M | 13.59%-3.89M | 36.38%-6.95M |
Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | ---30.37M | --0 | --0 | --0 | ---30.37M |
Net investment purchase and sale | -1,074.60%-48.47M | -162.36%-40.54M | -10.66%-25.62M | -199.62%-6.99M | -32.48%24.68M | 111.23%4.97M | 65.58%-15.45M | -307.61%-23.15M | 168.12%7.02M | 15,460.08%36.56M |
Net other investing changes | --2.03M | --0 | --0 | --0 | --2.03M | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -21.03%-64.55M | -74.83%-45.72M | -0.22%-29.61M | -417.90%-9.94M | 2,819.82%20.73M | 22.58%-53.33M | 45.20%-26.15M | -715.54%-29.55M | 121.13%3.13M | 93.17%-762K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -168.78%-12.58M | 75.81%-254K | 153.95%895K | -93.64%1.62M | 45.92%-14.84M | -2.86%-4.68M | -392.48%-1.05M | -2,254.55%-1.66M | 3,071.86%25.47M | -374.02%-27.44M |
Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | --4.21M | --0 | --0 | --24.38M | ---20.17M |
Proceeds from stock option exercised by employees | 14.83%5.3M | 2.52%935K | 8.74%1.18M | 35.56%1.87M | 6.20%1.32M | 24.88%4.62M | 15.59%912K | 39.36%1.09M | 21.84%1.38M | 24.35%1.24M |
Net other financing activities | -32.37%-17.88M | 39.40%-1.19M | 89.55%-287K | 15.07%-248K | -89.89%-16.16M | -63.79%-13.51M | -356.28%-1.96M | -290.61%-2.75M | 10.98%-292K | -25.37%-8.51M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -168.78%-12.58M | 75.81%-254K | 153.95%895K | -93.64%1.62M | 45.92%-14.84M | -2.86%-4.68M | -392.48%-1.05M | -2,254.55%-1.66M | 3,071.86%25.47M | -374.02%-27.44M |
Net cash flow | ||||||||||
Beginning cash position | 2.35%159.12M | 4.27%163.49M | -3.60%174.45M | 23.46%174.32M | 2.35%159.12M | 29.05%155.47M | -7.59%156.8M | 53.82%180.96M | 10.04%141.2M | 29.05%155.47M |
Current changes in cash | -463.29%-13.31M | -869.63%-17.59M | 54.03%-11.1M | -99.67%131K | 206.73%15.25M | -89.55%3.66M | 116.03%2.29M | -146.37%-24.15M | 474.87%39.82M | -282.14%-14.29M |
Effect of exchange rate changes | 162.50%10K | -313.16%-81K | 1,138.46%135K | 96.08%-2K | -520.00%-42K | 69.81%-16K | -30.91%38K | 77.19%-13K | -6.25%-51K | 433.33%10K |
End cash Position | -8.36%145.82M | -8.36%145.82M | 4.27%163.49M | -3.60%174.45M | 23.46%174.32M | 2.35%159.12M | 2.35%159.12M | -7.59%156.8M | 53.82%180.96M | 10.04%141.2M |
Free cash flow | 35.44%45.7M | 23.53%23.21M | 1,967.22%13.62M | -24.91%5.5M | -51.65%3.37M | -59.77%33.74M | -37.95%18.79M | -98.39%659K | 753.61%7.33M | -49.73%6.97M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |